These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

374 related items for PubMed ID: 33084500

  • 1. Overview of Riociguat and Its Role in the Treatment of Pulmonary Hypertension.
    Kenny M, Clarke MM, Pogue KT.
    J Pharm Pract; 2022 Jun; 35(3):437-444. PubMed ID: 33084500
    [Abstract] [Full Text] [Related]

  • 2. Riociguat for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
    Bishop BM.
    Am J Health Syst Pharm; 2014 Nov 01; 71(21):1839-44. PubMed ID: 25320133
    [Abstract] [Full Text] [Related]

  • 3. Riociguat: a soluble guanylate cyclase stimulator for the treatment of pulmonary hypertension.
    Lian TY, Jiang X, Jing ZC.
    Drug Des Devel Ther; 2017 Nov 01; 11():1195-1207. PubMed ID: 28458514
    [Abstract] [Full Text] [Related]

  • 4. Riociguat: Mode of Action and Clinical Development in Pulmonary Hypertension.
    Ghofrani HA, Humbert M, Langleben D, Schermuly R, Stasch JP, Wilkins MR, Klinger JR.
    Chest; 2017 Feb 01; 151(2):468-480. PubMed ID: 27263466
    [Abstract] [Full Text] [Related]

  • 5. Riociguat and the right ventricle in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
    Benza RL, Langleben D, Hemnes AR, Vonk Noordegraaf A, Rosenkranz S, Thenappan T, Hassoun PM, Preston IR, Ghio S, Badagliacca R, Vizza CD, Lang IM, Meier C, Grünig E.
    Eur Respir Rev; 2022 Dec 31; 31(166):. PubMed ID: 36198418
    [Abstract] [Full Text] [Related]

  • 6. Riociguat: a review of its use in patients with chronic thromboembolic pulmonary hypertension or pulmonary arterial hypertension.
    Garnock-Jones KP.
    Drugs; 2014 Nov 31; 74(17):2065-78. PubMed ID: 25352393
    [Abstract] [Full Text] [Related]

  • 7. Riociguat: a novel therapeutic option for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
    Mielniczuk LM, Swiston JR, Mehta S.
    Can J Cardiol; 2014 Oct 31; 30(10):1233-40. PubMed ID: 25154043
    [Abstract] [Full Text] [Related]

  • 8. Right ventricular size and function under riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (the RIVER study).
    Marra AM, Halank M, Benjamin N, Bossone E, Cittadini A, Eichstaedt CA, Egenlauf B, Harutyunova S, Fischer C, Gall H, Ghofrani HA, Hoeper MM, Lange TJ, Olsson KM, Klose H, Grünig E.
    Respir Res; 2018 Dec 19; 19(1):258. PubMed ID: 30567595
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry.
    Ghofrani HA, Gomez Sanchez MA, Humbert M, Pittrow D, Simonneau G, Gall H, Grünig E, Klose H, Halank M, Langleben D, Snijder RJ, Escribano Subias P, Mielniczuk LM, Lange TJ, Vachiéry JL, Wirtz H, Helmersen DS, Tsangaris I, Barberá JA, Pepke-Zaba J, Boonstra A, Rosenkranz S, Ulrich S, Steringer-Mascherbauer R, Delcroix M, Jansa P, Šimková I, Giannakoulas G, Klotsche J, Williams E, Meier C, Hoeper MM, NEW COLLABORATORS LIST.
    Respir Med; 2021 Mar 19; 178():106220. PubMed ID: 33540340
    [Abstract] [Full Text] [Related]

  • 11. Change of right heart size and function by long-term therapy with riociguat in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
    Marra AM, Egenlauf B, Ehlken N, Fischer C, Eichstaedt C, Nagel C, Bossone E, Cittadini A, Halank M, Gall H, Olsson KM, Lange TJ, Grünig E.
    Int J Cardiol; 2015 Sep 15; 195():19-26. PubMed ID: 26011408
    [Abstract] [Full Text] [Related]

  • 12. [The achievements of the modern specific therapy of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: focus on the stimulator of soluble guanylate cyclase riociguat].
    Gratsianskaya SE, Valieva ZS, Martynyuk TV.
    Ter Arkh; 2020 Oct 14; 92(9):77-84. PubMed ID: 33346435
    [Abstract] [Full Text] [Related]

  • 13. Riociguat for the treatment of pulmonary hypertension: a safety evaluation.
    Binder C, Zotter-Tufaro C, Bonderman D.
    Expert Opin Drug Saf; 2016 Dec 14; 15(12):1671-1677. PubMed ID: 27750459
    [Abstract] [Full Text] [Related]

  • 14. Treatment of pulmonary hypertension with riociguat: a review of current evidence and future perspectives.
    Boutou AK, Pitsiou G.
    Expert Opin Pharmacother; 2020 Jul 14; 21(10):1145-1155. PubMed ID: 32089012
    [Abstract] [Full Text] [Related]

  • 15. Riociguat: an upcoming therapy in chronic thromboembolic pulmonary hypertension?
    Kim NH.
    Eur Respir Rev; 2010 Mar 14; 19(115):68-71. PubMed ID: 20956169
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of riociguat in the treatment of chronic thromboembolic pulmonary arterial hypertension: A meta-analysis.
    Ying M, Song J, Gu S, Zhao R, Li M.
    Medicine (Baltimore); 2021 Jun 04; 100(22):e26211. PubMed ID: 34087896
    [Abstract] [Full Text] [Related]

  • 17. Riociguat: a novel new drug for treatment of pulmonary hypertension.
    Makowski CT, Rissmiller RW, Bullington WM.
    Pharmacotherapy; 2015 May 04; 35(5):502-19. PubMed ID: 26011143
    [Abstract] [Full Text] [Related]

  • 18. Riociguat: Clinical research and evolving role in therapy.
    Klinger JR, Chakinala MM, Langleben D, Rosenkranz S, Sitbon O.
    Br J Clin Pharmacol; 2021 Jul 04; 87(7):2645-2662. PubMed ID: 33242341
    [Abstract] [Full Text] [Related]

  • 19. Riociguat: first global approval.
    Conole D, Scott LJ.
    Drugs; 2013 Nov 04; 73(17):1967-75. PubMed ID: 24218053
    [Abstract] [Full Text] [Related]

  • 20. [Riociguat: stimulator of soluble guanylate-cyclase. New mode of action for the treatment of pulmonary arterial and non operable chronic thromboembolic pulmonary hypertension].
    Leuchte HH, Behr J, Ewert R, Ghofrani HA, Grünig E, Halank M, Held M, Klose H, Rosenkranz S, Schermuly RT, Wilkens H, Hoeper MM.
    Pneumologie; 2015 Mar 04; 69(3):135-43. PubMed ID: 25750094
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.